The Catalog of Somatic Mutations in Cancer (COSMIC) (http://cancer.sanger.ac.uk) database reveals that specific cancer mutations located in the transmembrane domain (TMD) of BCL2 [14, 15]; while said mutations suffer from low frequency, they have been classified as potentially tumorigenic. This evidence concerns the gene BCL2 and cancer.